Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on Ecovyst, Lowers Price Target to $18

Keybanc analyst Aleksey Yefremov maintains Ecovyst (NYSE:ECVT) with a Overweight and lowers the price target from $21 to $18.

byBenzinga Newsdesk

August 17, 2021

1 minute read

Keybanc analyst Aleksey Yefremov maintains Ecovyst (NYSE:ECVT) with a Overweight and lowers the price target from $21 to $18.

Needham Maintains Buy on MKS Instruments, Raises Price Target to $110

By Benzinga Newsdesk

December 15, 7:57 AM

Needham analyst James Ricchiuti maintains MKS Instruments (NASDAQ:MKSI) with a Buy and raises the price target from $90 to $110.

MKSI

Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance

By Vandana Singh

May 6, 2:21 PM

Natera Inc (NASDAQ:NTRA) generated Q1 revenues of $194.1 million, up 27.5% Y/Y, beating the consensus of $176.60 million. Product revenues…

NTRA

FDA
News

Thorne Relaunches Its Gut Health Test

By Benzinga Newsdesk

May 24, 8:09 AM

Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and well-being, today relaunched its Gut

THRN

FDA
News

President Of World Organization For Animal Health William Karesh Says Evidence Of Monkeypox Susceptibility In Various Species Of Shrews, Squirrels And Rats

By Benzinga Newsdesk

June 2, 8:38 AM

-Reuters-Reuters

AEMD

Keybanc Maintains Overweight on Ecovyst, Lowers Price Target to $18

Related Posts

Needham Maintains Buy on MKS Instruments, Raises Price Target to $110

Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance

Thorne Relaunches Its Gut Health Test

President Of World Organization For Animal Health William Karesh Says Evidence Of Monkeypox Susceptibility In Various Species Of Shrews, Squirrels And Rats